Pfizer
Short Term
We look to Sell at 54.06 (stop at 56.08)
Bespoke resistance is located at 54.50. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 54.60 level. We are trading at overbought extremes.
Our...
Pfizer
Short Term - We look to Sell at 54.62 (stop at 56.31)
Bespoke resistance is located at 54.70. A move higher faces tough resistance and we remain cautious on upside potential. Selling spikes offers good risk/reward. Further downside is expected although we prefer to sell into rallies close to the 54.60 level. Trading has been mixed and volatile.
Our...
Pfizer - Short Term - We look to Sell at 49.33 (stop at 51.54)
The trend of lower highs is located at 53.50. Previous support located at 50.00. A move through bespoke support at 50.00 and we look for extended losses. Closed below the 20-day EMA. The medium term bias remains bearish.
Our profit targets will be 43.51 and 41.00
Resistance: 54.00 / 57.00 /...
Hello Traders,
welcome to this free and educational analysis.
I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities.
If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below.
I will personally reply to every single...
PFE has bounced up from support @ 41.5 using Aspen Trading Support & Resistance Levels.
Next target is 49.5 and a move above this level can lead to further upside.
More tailwinds, it is above 50 & 200 moving averages and PFE typically displays seasonal strength this time of year.
Please like, share and follow if you agree with the analysis.
Note - Aspen...
Pfizer has grown an authority at being first. The pharmaceutical behemoth was the pioneer to introduce a coronavirus vaccine a year ago. Since then, it has had several other successes: bringing the COVID-19 booster to market, getting approval for its vaccine for adolescents, and most recently getting approval for a vaccine for children.
This has been followed by...
SNIPER STRATEGY (new version)
It works ALMOST ON ANY CHART.
It produces Weak, Medium and Strong signals based on consisting elements.
NOT ALL TARGETS CAN BE ACHIEVED, let's make that clear.
TARGETS OR ENTRY PRICES ARE STRONG SUPPORT AND RESISTANCE LEVELS.
ENTRY PRICE BLACK COLOR
TARGETS GREEN COLOR
STOP LOSS RED COLOR
DO NOT USE THIS...
SNIPER STRATEGY
This magical strategy works like a clock on almost any charts
Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading.
It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave.
The best timeframe for this strategy is Daily, Weekly and Monthly...
WITH BIG NEW FROM PRESIDENT BIDEN THIS WEEK SUPPLYING OVER 500 MILLION VACCINES AROUND THE WORLD. PFIZER LOOKS READY FOR ITS NEXT BULL RUN, WITH A PERFECT ENTRY BUY CANDLE ON THE WEEKLY TIMEFRAME.
#BLESSEDPIPS
Pfizer (NYSE:PFE) finally broke through the $36 price level on solid volume. Look for the stock to test the prior highs of January. From a technical standpoint daily technical indicators are looking bullish. The MACD is above its signal line and is moving up in positive territory. RSI is still above its 50% level. Keep it on your watch list going forward.
